Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. (NASDAQ: DH) is a data and analytics company focused on healthcare commercial intelligence, and its news flow reflects this role in the U.S. healthcare market. The company regularly issues press releases detailing quarterly financial results, business performance and guidance, giving investors and analysts insight into trends in its subscription-based platform and related metrics.
News about Definitive Healthcare often includes earnings announcements for its fiscal quarters, where it discusses revenue, net loss or income, non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income, and cash flow metrics. These releases also highlight customer wins across end markets like medical device companies, digital health organizations, healthcare revenue cycle management firms, regional health systems, healthcare-focused private equity firms and healthcare advertising agencies.
Another important category of news involves corporate developments and leadership updates. The company reports inducement equity awards to senior leaders, changes in executive roles, and board-level updates, such as director resignations and committee appointments. These items provide context on how Definitive Healthcare structures its leadership and aligns compensation with its growth plans.
Definitive Healthcare also announces its participation in investor conferences and the timing of its quarterly financial results conference calls and webcasts. These updates indicate when management will discuss financial performance and outlook with the investment community.
By following the DH news feed, readers can monitor the company’s financial disclosures, leadership and governance changes, customer and market highlights, and investor relations events in one place. This page can be a useful reference for tracking how Definitive Healthcare communicates its progress and priorities over time.
Definitive Healthcare (Nasdaq: DH) has launched Monocl Conferences, a solution designed to enhance conference planning and participation for life science organizations. This intuitive platform provides medical affairs, marketing, and conference planning teams with rich, contextualized conference data and access to key experts.
Key features include:
- Visualized conference data dashboard
- Searchable conference insights
- Comparable data for monitoring trends
Monocl Conferences offers quick access to presentations, competitor analysis, social media insights, and details about centers of excellence. It aims to streamline planning, drive strategic engagement, and support organizations in delivering innovative therapies and medical devices to improve patient outcomes.
Definitive Healthcare (Nasdaq: DH) has launched Market Forecast, a predictive analytics solution designed to help healthcare organizations identify high-growth markets and service line opportunities. This new tool provides three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities.
Market Forecast aims to empower business development teams, service line leaders, and strategy executives by delivering year-over-year growth rate and market demand projections. This enables healthcare organizations to:
- Drive improved patient acquisition and retention
- Plan market expansion
- Allocate resources more effectively
The solution is particularly valuable for academic medical centers and other healthcare providers looking to identify services with the greatest potential for future growth, even when current volumes may not reflect that opportunity.
Definitive Healthcare Corp. (Nasdaq: DH), a leader in healthcare commercial intelligence, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. Rick Booth, the company's Chief Financial Officer, is scheduled to present on Thursday, September 5, 2024, at 8:30 a.m. Eastern Time.
Investors and interested parties can access a live webcast of the presentation through the Events page on Definitive Healthcare's investor relations website at https://ir.definitivehc.com/. For those unable to attend the live event, a replay of the webcast will be available for a time after the presentation.
Definitive Healthcare (Nasdaq: DH) has expanded its Population Intelligence platform to serve a wider range of industries selling into healthcare. The platform now supports businesses in sectors like advertising, marketing, telehealth, staffing, and medical supply to enhance marketing campaigns and digital advertising performance.
Population Intelligence combines clinical and consumer data on over 250 million unique consumers aged 18+, offering 300+ clinical propensity, social determinants of health, and media channel models. This allows businesses to create precise audience segments and launch targeted marketing campaigns, driving efficient consumer activation.
The platform enables teams to segment markets, build campaign audiences, and activate audiences for digital advertising. It integrates with organizations' internal systems while keeping first-party data secure, promoting compliance with data privacy standards.
Definitive Healthcare Corp. (Nasdaq: DH) reported financial results for Q2 2024. Revenue grew 5% year-over-year to $63.7 million. The company incurred a net loss of $306.2 million, primarily due to goodwill impairment charges of $363.6 million. However, Adjusted EBITDA increased 21% to $20.9 million, representing 33% of revenue.
Key highlights include:
- Adjusted Net Income: $14.2 million
- Cash Flow from Operations: $14.0 million
- Unlevered Free Cash Flow: $21.5 million
- Enterprise customers grew by 32 (6% YoY) to 537
For Q3 2024, DH expects revenue between $61.0-$62.5 million and Adjusted EBITDA of $17.5-$19.0 million. Full-year 2024 guidance projects revenue of $247-$251 million and Adjusted EBITDA of $74-$77 million.
Definitive Healthcare Corp. (Nasdaq: DH), a leader in healthcare commercial intelligence, has announced the timing for its second quarter 2024 financial results conference call and webcast. The company will report its financial results for the quarter ended June 30, 2024, on Monday, August 5, 2024, after market close.
A conference call and webcast will be held at 5:00 PM (ET) / 2:00 PM (PT) to discuss the results. Investors can access the live audio webcast on the company's Investor Relations website. A live dial-in will also be available. Following the call, a replay will be accessible through September 4, 2024.
Definitive Healthcare (Nasdaq: DH) has launched a redesigned mobile app for its View Suite platform, aimed at enhancing accessibility to healthcare commercial intelligence. Announced on July 09, 2024, the new DH View Suite mobile app provides sales and marketing teams with instant access to essential data, optimizing their productivity in the field. The app offers detailed profiles of healthcare professionals and organizations, including metrics on clinical performance, finances, and more. Available for download on Apple and Android devices at no additional cost to existing customers, the app ensures that users are always prepared for client meetings and industry events.
On June 25, 2024, Definitive Healthcare (Nasdaq: DH) announced the granting of inducement awards to its new CEO, Kevin Coop. The awards include 1,137,038 performance-based restricted stock units (PSUs) and 1,170,047 time-based restricted stock units (RSUs), effective June 24, 2024. These grants are in accordance with Nasdaq Listing Rule 5635(c)(4) and are a part of the company's 2023 Inducement Plan.
The RSUs will vest in stages, with one-fourth vesting on July 1, 2025, and the rest in 12 equal quarterly installments. The PSUs are divided into four tranches, tied to specific stock price hurdles and performance periods, with vesting subject to the Human Capital Management and Compensation Committee's certification and Mr. Coop's continued service.
Definitive Healthcare (Nasdaq: DH) has been awarded the 2024 Databricks Healthcare and Life Sciences Partner of the Year. This accolade highlights their successful collaboration with Databricks in offering innovative data and AI solutions to the healthcare and life sciences sector.
Leveraging the Databricks Marketplace, Definitive Healthcare provides access to extensive datasets, including prescription claims, behavioral health data, and affiliations intelligence. This aids organizations in understanding patient journeys, prioritizing opportunities, and engaging key medical experts for better healthcare outcomes.
Casey Eastlack, AVP at Definitive Healthcare, expressed pride in the recognition, emphasizing the shared mission to deliver deeper and faster healthcare insights for improved decision-making and innovation. Michael Sanky of Databricks praised the partnership's impact on advancing outcomes for customers in the sector.
Definitive Healthcare (Nasdaq: DH) published its 2023 Sustainability Report, showcasing its achievements in environmental, social, and governance (ESG) practices. Highlights include the retention of an ESG consultant to measure greenhouse gas emissions, and the closure of its least energy-efficient office. On the social front, the company improved diversity at the executive level, contributed 1,940 volunteer hours, and raised over $300,000 in charitable donations. In governance, Definitive Healthcare completed a SOC2 assessment and enhanced its cybersecurity and data privacy framework.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
